Today's Date
Michele DesMarais
Assessment Group
Transplantation
Work:
415-420-4250
Mobile:
Address:
Immune Tolerance Network
Committees:
,
Studies:

ITN022ST
-
Using Donor Stem Cells and Alemtuzumab to Prevent Organ Rejection in Kidney Transplant Patients
ITN024ST
-
Immune System Suppression With Alemtuzumab and Tacrolimus in Liver Transplantation Patients
ITN030ST
-
Gradual Withdrawal of Immune System Suppressing Drugs in Patients Receiving a Liver TransplantBio: